SIGA Technologies (SIGA) Competitors $5.52 -0.24 (-4.17%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. AAPG, ARWR, HRMY, GLPG, CNTA, ARQT, IDYA, AGIO, CGON, and ANIPShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Ascentage Pharma Group International (AAPG), Arrowhead Pharmaceuticals (ARWR), Harmony Biosciences (HRMY), Galapagos (GLPG), Centessa Pharmaceuticals (CNTA), Arcutis Biotherapeutics (ARQT), IDEAYA Biosciences (IDYA), Agios Pharmaceuticals (AGIO), CG Oncology (CGON), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry. SIGA Technologies vs. Ascentage Pharma Group International Arrowhead Pharmaceuticals Harmony Biosciences Galapagos Centessa Pharmaceuticals Arcutis Biotherapeutics IDEAYA Biosciences Agios Pharmaceuticals CG Oncology ANI Pharmaceuticals Ascentage Pharma Group International (NASDAQ:AAPG) and SIGA Technologies (NASDAQ:SIGA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, dividends, valuation, earnings, media sentiment, institutional ownership and profitability. Does the MarketBeat Community believe in AAPG or SIGA? SIGA Technologies received 4 more outperform votes than Ascentage Pharma Group International when rated by MarketBeat users. However, 100.00% of users gave Ascentage Pharma Group International an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformAscentage Pharma Group InternationalOutperform Votes1100.00% Underperform VotesNo VotesSIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% Which has higher valuation and earnings, AAPG or SIGA? SIGA Technologies has lower revenue, but higher earnings than Ascentage Pharma Group International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$980.65M2.17N/AN/AN/ASIGA Technologies$138.72M2.84$68.07M$0.826.73 Do institutionals and insiders hold more shares of AAPG or SIGA? 55.4% of SIGA Technologies shares are held by institutional investors. 1.5% of SIGA Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is AAPG or SIGA more profitable? SIGA Technologies has a net margin of 49.33% compared to Ascentage Pharma Group International's net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat Ascentage Pharma Group International's return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A SIGA Technologies 49.33%49.06%38.72% Do analysts prefer AAPG or SIGA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer AAPG or SIGA? In the previous week, Ascentage Pharma Group International had 3 more articles in the media than SIGA Technologies. MarketBeat recorded 6 mentions for Ascentage Pharma Group International and 3 mentions for SIGA Technologies. SIGA Technologies' average media sentiment score of 1.09 beat Ascentage Pharma Group International's score of 0.51 indicating that SIGA Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SIGA Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySIGA Technologies beats Ascentage Pharma Group International on 8 of the 13 factors compared between the two stocks. Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$394.35M$6.89B$5.57B$7.83BDividend YieldN/A3.06%5.11%4.21%P/E Ratio4.607.4422.4418.48Price / Sales2.84242.73394.10103.59Price / Cash6.3465.8538.1834.62Price / Book1.996.516.774.25Net Income$68.07M$143.21M$3.22B$248.23M7 Day Performance-14.81%1.98%1.48%0.89%1 Month Performance0.73%6.89%3.99%3.53%1 Year Performance-40.74%-2.52%16.20%5.08% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies1.852 of 5 stars$5.52-4.2%N/A-37.1%$394.35M$138.72M4.6040Upcoming EarningsOptions VolumePositive NewsAAPGAscentage Pharma Group InternationalN/A$19.12+2.1%N/AN/A$1.66B$980.65M0.00600News CoverageARWRArrowhead Pharmaceuticals3.6152 of 5 stars$12.08+7.5%$41.44+243.1%-38.6%$1.66B$2.50M-2.34400News CoveragePositive NewsGap DownHRMYHarmony Biosciences4.8542 of 5 stars$28.50+0.1%$53.33+87.1%-4.7%$1.63B$714.73M13.51200Upcoming EarningsAnalyst ForecastPositive NewsGLPGGalapagos0.5894 of 5 stars$24.64-0.1%$25.33+2.8%-5.4%$1.62B$275.65M0.001,310Options VolumeCNTACentessa Pharmaceuticals2.5563 of 5 stars$12.15-1.2%$27.71+128.1%+49.7%$1.62B$6.85M-7.94200News CoveragePositive NewsARQTArcutis Biotherapeutics2.7534 of 5 stars$13.53+4.0%$18.80+39.0%+79.2%$1.61B$196.54M-7.56150Upcoming EarningsPositive NewsGap DownIDYAIDEAYA Biosciences3.6803 of 5 stars$18.18+6.4%$53.58+194.7%-50.5%$1.59B$7M-5.5180Upcoming EarningsAGIOAgios Pharmaceuticals4.3137 of 5 stars$27.34-1.2%$56.57+106.9%-8.6%$1.57B$36.50M2.41390Upcoming EarningsNews CoveragePositive NewsCGONCG Oncology2.0957 of 5 stars$20.41-1.1%$59.33+190.7%-33.0%$1.56B$1.14M-14.3761Upcoming EarningsAnalyst ForecastNews CoverageANIPANI Pharmaceuticals4.3469 of 5 stars$68.00-1.7%$80.13+17.8%+7.3%$1.48B$614.38M-123.64600 Related Companies and Tools Related Companies Ascentage Pharma Group International Alternatives Arrowhead Pharmaceuticals Alternatives Harmony Biosciences Alternatives Galapagos Alternatives Centessa Pharmaceuticals Alternatives Arcutis Biotherapeutics Alternatives IDEAYA Biosciences Alternatives Agios Pharmaceuticals Alternatives CG Oncology Alternatives ANI Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SIGA Stock Free SIGA Stock Alerts